Clinical Trials List
Protocol NumberCDKY709A12101C
Completed
2019-10-03 - 2025-05-05
Phase I
Recruiting1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- YEN-TING LIN Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- Chong-Jen Yu Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 吳尚俊 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8~16 participants
-
Global
380 participants
